×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| KILITCH DRUGS (INDIA) LTD. | 578.91 | 56.15 | 561.66 | 3.71 | 528.0 | 29.5 |
| ALBERT DAVID LTD. | 740.76 | -93.88 | 830.83 | -16.45 | 509 | 12.6 |
| ZIM Laboratories Limited | 980.85 | 40.01 | 963.3 | 0.82 | 473 | 30.8 |
Kilitch Drugs (I) Ltd., with Security Code 524500, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23.5 | 22.4 | 28.5 | 43.2 | 31.1 | 31.5 | 29.7 | 39.1 | 33.4 | 45.3 |
| Expenses | 20.4 | 19.3 | 24.3 | 36.6 | 25.9 | 25.9 | 25.7 | 33.9 | 30.2 | 39.8 |
| Operating Profit | 3.1 | 3.1 | 4.2 | 6.7 | 5.2 | 5.7 | 4.0 | 5.2 | 3.2 | 5.6 |
| OPM % | 13.27% | 14.02% | 14.79% | 15.45% | 16.83% | 18.11% | 13.5% | 13.33% | 9.63% | 12.33% |
| Other Income | 1.4 | 0.7 | 1.1 | 1.4 | 1.0 | 0.9 | 3.4 | 0.9 | 3.2 | 5.8 |
| Interest | 0.1 | 0.2 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.5 | 0.4 |
| Depreciation | 0.3 | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.4 | 0.3 | 0.4 |
| Profit before tax | 4.2 | 3.3 | 4.7 | 7.3 | 5.6 | 5.9 | 6.6 | 5.3 | 5.6 | 10.6 |
| Tax % | 27.8% | 11.7% | 15.9% | 30.1% | 24.9% | 28.5% | 16.4% | 30.7% | 27.5% | 16.4% |
| Net Profit | 3.0 | 3.6 | 3.9 | 5.1 | 4.2 | 4.2 | 5.5 | 3.6 | 4.1 | 8.8 |
| EPS in Rs | 1.93 | 2.34 | 2.53 | 3.29 | 2.69 | 2.6 | 3.48 | 2.26 | 2.52 | 5.5 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30.7 | 30.0 | 45.5 | 36.6 | 41.2 | 31.8 | 44.8 | 33.5 | 47.5 | 56.2 |
| Expenses | 26.7 | 26.0 | 39.3 | 30.4 | 32.6 | 29.5 | 37.7 | 31.8 | 41.4 | 47.4 |
| Operating Profit | 4.0 | 4.0 | 6.2 | 6.2 | 8.6 | 2.3 | 7.1 | 1.7 | 6.1 | 8.7 |
| OPM % | 12.9% | 13.3% | 13.7% | 16.9% | 20.9% | 7.2% | 15.8% | 5% | 12.8% | 15.6% |
| Other Income | 0.2 | 0.7 | 1.0 | 0.6 | 0.5 | 3.0 | 0.5 | 2.6 | 5.2 | 1.7 |
| Interest | 1.8 | 1.3 | 1.2 | 1.5 | 1.5 | 1.6 | 1.3 | 1.7 | 0.3 | 1.4 |
| Depreciation | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 | 0.8 | 0.9 | 0.9 | 0.6 | 0.8 |
| Profit before tax | 1.6 | 2.5 | 5.1 | 4.5 | 6.8 | 2.8 | 5.3 | 1.7 | 10.3 | 8.3 |
| Tax % | 24.6% | 30.3% | 43.3% | 31.3% | 24.9% | 38.3% | 30.5% | 93.2% | 16.8% | 31.9% |
| Net Profit | 1.9 | 1.7 | 2.9 | 3.1 | 5.1 | 1.7 | 3.7 | 0.1 | 8.6 | 5.6 |
| EPS in Rs | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 0 | 5 | 3 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 6% |
| 3 Years: | 23% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 5% |
| 3 Years: | 47% |
| TTM: | 23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 24% |
| 3 Years: | 23% |
| 1 Year: | -17% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 13% |
| 3 Years: | 31% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 35% |
| 3 Years: | 64% |
| TTM: | 44% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 24% |
| 3 Years: | 23% |
| 1 Year: | -17% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|